Physician profile
James Carroll
NPI 1417618729
$1,063.69
in general payments reported to CMS, 2019-2025
16 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $108 · 2023: $153 · 2024: $487 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $390.73 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbvie INC. | $135.62 | 2023-2025 | |
| Scilex Pharmaceuticals INC. | $122.07 | 2022-2025 | Ztlido |
| Pfizer INC. | $99.69 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.27 | 2022-2025 | Relistor |
| Biohaven Pharmaceutical Holding Company LTD. | $33.96 | 2022 | |
| Globus Medical, INC. | $33.24 | 2025 | Senza |
| Lundbeck LLC | $30.55 | 2024-2025 | Vyepti |
| Vertex Pharmaceuticals Incorporated | $22.25 | 2024 | |
| Averitas Pharma INC. | $18.04 | 2023 | Qutenza |
| Nalu Medical, INC. | $17.57 | 2024 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $15.79 | 2022 | |
| Electronic Waveform Lab, INC. | $15.11 | 2025 | |
| Collegium Pharmaceutical, INC. | $14.83 | 2024 | Belbuca |
| Cepheid | $14.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $4.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.